FIELD: medicine.
SUBSTANCE: declared is application of embryonic antitumour modulator (EATM) as agent of antimetastatic action. EATM is made of embryonic substances by cryodestruction, extraction and precipitation in alcohols of increasing concentration and contains proteoglycan complex of hyaluronic acid, tumour-associated antigens of normal embryogenesis.
EFFECT: provides antimetastatic action.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING AND APPLYING EMBRYONIC ANTITUMOR MODULATOR AGENT | 2002 |
|
RU2240810C2 |
| NONSPECIFIC IMMUNOTHERAPY AGENT | 2007 |
|
RU2341272C1 |
| ANTIMETASTATIC DRUG | 1993 |
|
RU2023446C1 |
| PEPTIDE, POSSESSING ANTI-TUMOR AND ANTI-METASTATIC ACTIVITY, AND FINISHED DOSAGE FORM BASED THEREON | 2018 |
|
RU2682039C1 |
| METHOD OF TREATING ONCOLOGICAL DISEASES IN EXPERIMENT | 2007 |
|
RU2396967C2 |
| PHARMACEUTICAL COMPOSITION BASED ON PALLADIUM COMPOUND | 2015 |
|
RU2613305C2 |
| ANTI-METASTATIC AGENT | 2017 |
|
RU2657814C1 |
| MEANS FOR ANTIMETASTATIC ACTIVITY AND IMPROVED ANTIMETASTATIC ACTION OF CYCLOPHOSPHANE | 2016 |
|
RU2657602C1 |
| AGENT WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY, ANTI-INFLAMMATORY AND ANTIALLERGIC ACTION | 2018 |
|
RU2686672C1 |
| SUBSTITUTED AMIDES OF 2-/2'(5"-NITROFURYL-2")-VINYL-AND 4-(5"-NITROFURYL-2")-1,3-BUTADIENYL/-QUINOLINE-4-CARBOXYLIC ACIDSOR THEIR WATER-SOLUBLE SALTS POSSESSING ANTIBLASTIC ACTIVITY | 0 |
|
SU763345A1 |
